Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Morbid Obesity
NCT02035397Phase 2Unknown
- Sponsor
- Norwegian University of Science and Technology
- Start
- Feb 2014
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in obesity, sponsored by Norwegian University of Science and Technology. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02035397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02035397.